Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galapagos (GLPG)
NASDAQ:GLPG
Holding GLPG?
Track your performance easily
Earnings Data
Report Date
Feb 12, 2025After Close Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.5Last Year’s EPS
$2.59Same Quarter Last Year
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 30, 2024
|% Change Since: -6.40%
|Next Earnings Date:Feb 12, 2025
Earnings Call Sentiment|Positive
The earnings call presented a strong strategic and financial position, with significant regulatory achievements and a robust pipeline. However, there were increases in R&D costs and challenges in CAR-T development. The highlights, particularly the strong cash position and regulatory advancements, outweigh the lowlights.Company Guidance
During Galapagos' Q3 2024 earnings call, the company provided detailed guidance on their robust pipeline and strong financial position. They reported a cash position of EUR 3.3 billion as of the end of September 2024 and a net profit of EUR 49 million for the first nine months, driven by EUR 71 million in interest income and fair value adjustments. The company reconfirmed their full-year cash burn guidance of EUR 370 million to EUR 410 million, with a reported cash burn of EUR 346 million in the first nine months, including EUR 321 million from operations. Their R&D efforts are focused on advancing 4 clinical candidates for 11 indications, with over 15 preclinical programs, and they plan to initiate at least four IND or CTA-enabling studies in 2025. Key regulatory achievements included the FDA's IND clearance for the GLPG5101 study in non-Hodgkin lymphoma and the resumption of recruitment for the GLPG5301 study in multiple myeloma. The company is also expanding its decentralized CAR-T network in the U.S. and Europe, aiming to leverage their novel point-of-care solutions to improve patient outcomes.Strong Cash Position
Galapagos reported a strong cash position of EUR 3.3 billion at the end of September 2024, supporting future growth and pipeline development.
FDA IND Clearance for GLPG5101
Galapagos received IND clearance from the FDA for GLPG5101 in non-Hodgkin lymphoma, enabling the start of the Phase II expansion part of the ATALANTA study in the U.S.
Regulatory Progress in Decentralized CAR-T
Significant regulatory progress with the 7-day vein-to-vein CAR-T manufacturing process, enabling further cell therapy development in the U.S.
Net Profit and Interest Income
Galapagos recorded a net profit of EUR 49 million over the first 9 months of 2024, driven by EUR 71 million in interest income.
Anticipated Milestones
Galapagos plans to initiate at least 4 IND/CTA-enabling studies in 2025 and aims to fuel the clinical pipeline with at least 2 new clinical assets annually from 2026 onwards.
---
GLPG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GLPG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $28.59 | $26.44 | -7.52% |
| Aug 01, 2024 | $26.89 | $25.52 | -5.09% |
| May 02, 2024 | $29.45 | $29.09 | -1.22% |
| Feb 22, 2024 | $39.51 | $36.24 | -8.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Galapagos (GLPG) report earnings?
Galapagos (GLPG) is schdueled to report earning on Feb 12, 2025, After Close Not Confirmed.
What is Galapagos (GLPG) earnings time?
Galapagos (GLPG) earnings time is at Feb 12, 2025, After Close Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GLPG EPS forecast?
GLPG EPS forecast for the fiscal quarter 2024 (Q4) is -$0.5.
---